- Research works
- 40 ▼ 80% vs 2013–17
- Citations
- 894 22.3 per fractional work
- Top-10% rate
- 9.2% record average 16.5%
- Open access
- 33% world 28%
Not ranked overall: Isto Biologics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 2.5×. Every wedge is a field page.
Which keywords describe research at Isto Biologics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Genetic Mutations, Targeted Therapy, Mesenchymal Stem Cells, Clinical Trials, Biomarkers, Cancer Therapy and Regenerative Medicine.
- Small-Cell Lung Cancer
- Genomic Profiles
- Breast Cancer
- Metastasis
- DNA Methylation
- Pancreatic Neuroendocrine Tumors
- Tissue Engineering
- Chemotherapy
- Inflammation
- Regenerative Medicine
- Cancer
- Cancer Therapy
- Biomarkers
- Targeted Therapy
- Epidemiology
- Immunotherapy
- Genetic Mutations
- Clinical Trials
- Biomedical Applications
- Mesenchymal Stem Cells
- Regeneration
- Gene Therapy
- Prognostic Factors
- Stromal Cells
- Neuroendocrine Tumors
- Angiogenesis
- Differentiation
- Biomaterials
- Epigenetic Reprogramming
- Histone Modification
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 30 words, with their numbers
- Immunotherapy3▲ 13×6 topics
- Epidemiology3▲ 1.81×16 topics
- Genetic Mutations2▲ 10×4 topics
- Targeted Therapy2▲ 25×3 topics
- Clinical Trials2▲ 7.5×3 topics
- Biomarkers2▲ 7.4×3 topics
- Biomedical Applications2▲ 4.2×7 topics
- Cancer Therapy2▲ 7.2×5 topics
- Mesenchymal Stem Cells2▲ 39×3 topics
- Cancer2▲ 3.1×8 topics
- Regeneration2▲ 20×4 topics
- Regenerative Medicine2▲ 17×3 topics
- Gene Therapy1▲ 13×4 topics
- Inflammation1▲ 1.52×10 topics
- Prognostic Factors1▲ 8.0×4 topics
- Chemotherapy1▲ 4.5×3 topics
- Stromal Cells1▲ 37×2 topics
- Tissue Engineering1▲ 6.2×5 topics
- Neuroendocrine Tumors1▲ 74×1 topic
- Pancreatic Neuroendocrine Tumors1▲ 74×1 topic
- Angiogenesis1▲ 6.9×4 topics
- DNA Methylation1▲ 24×2 topics
- Differentiation1▲ 36×2 topics
- Metastasis1▲ 8.0×2 topics
- Biomaterials1▲ 13×3 topics
- Breast Cancer1▲ 8.9×3 topics
- Epigenetic Reprogramming1▲ 33×1 topic
- Genomic Profiles1▲ 72×1 topic
- Histone Modification1▲ 39×1 topic
- Small-Cell Lung Cancer1▲ 72×1 topic
Which research topics does Isto Biologics (United States) publish most on?
By volume in 2022–2025: Cancer-related Molecular Pathways, Advanced Breast Cancer Therapies, Integrated Circuits and Semiconductor Failure Analysis and Industrial Vision Systems and Defect Detection.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer-related Molecular Pathways Oncology 0 works
- 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 3 Integrated Circuits and Semiconductor Failure Analysis Electrical and Electronic Engineering 0 works
- 4 Industrial Vision Systems and Defect Detection Industrial and Manufacturing Engineering 0 works
- 5 Advancements in Photolithography Techniques Electrical and Electronic Engineering 0 works
- 6 Adipokines, Inflammation, and Metabolic Diseases Epidemiology 0 works
- 7 Medical Imaging and Analysis Biomedical Engineering 0 works
- 8 Bone Tissue Engineering Materials Biomedical Engineering 0 works
- 9 Autophagy in Disease and Therapy Epidemiology 0 works
- 10 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Isto Biologics (United States)'s research output changed?
Output in 2018–2022 was 80% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hopkinton
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.